SEC Form 4 · accession 0001209191-15-004216
CEPHEID · CPHD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David H Persing
Officer — EVP, Chief Med/Tech Officer · Director
Period of report
Jan 12, 2015
Accepted (ET)
Jan 14, 2015 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037760
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 12, 2015 | M | 5,000 | $8.43 | A | 9,062 | D | |
| Common Stock | Jan 12, 2015 | S | 5,000 | $56.90 | D | 4,062 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified option (right to buy)F2 | $8.43 | Jan 12, 2015 | M | 5,000 | D | — | Apr 28, 2016 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- F225% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.